humanized anti-GD2 antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for humanized anti-GD2 antibody, covering 2017-08-17 to 2017-08-17. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma [Phase 1]